CLEC9A and melanoma: In another study, Zeng et al. [131] synthesized Clec9A-specific oil-in-water nanoemulsions with either encapsulated full-size OVA antigen, OVA257–254 CD8 and OVA323–339 CD4 epitopes, or a mixture of six neoepitopes derived from somatic melanoma mutations.